Protagonist Therapeutics, Inc Operating Lease Liability
Protagonist Therapeutics, Inc (PTGX) had Operating Lease Liability of $10.32 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-02-25
- 2025-12-31: Operating Lease, Liability $10.32M.
- 2024-12-31: Operating Lease, Liability $10.87M.
- 2024-09-30: Operating Lease, Liability $10.90M.
- 2024-06-30: Operating Lease, Liability $10.97M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $10.32M 10-K · filed 2026-02-25 |
| 2024-12-31 | $10.87M 10-K · filed 2026-02-25 |
| 2024-09-30 | $10.90M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $10.97M 10-Q · filed 2024-08-06 |
| 2023-12-31 | $1.14M 10-K · filed 2025-02-21 |
| 2022-12-31 | $3.66M 10-K · filed 2024-02-27 |
| 2021-12-31 | $5.86M 10-K · filed 2023-03-15 |
| 2021-09-30 | $6.26M 10-Q · filed 2021-11-03 |
| 2020-12-31 | $5.96M 10-K · filed 2022-02-28 |
| 2019-12-31 | $7.22M 10-K · filed 2021-03-10 |
| 2019-09-30 | $7.50M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $7.78M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $8.04M 10-Q · filed 2019-05-08 |
| 2019-01-01 | $8.30M 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |